Skip to content
Home/Companies/Biotech/EpiBone
EpiBone

EpiBone

Biotech·US·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns EpiBone?

EpiBone is currently owned by EMV Capital through EMV Capital Evergreen Fund (2012 vintage), since 2020.

Hand-verified · updated 2026-07-08

EMV Capital
Investor
EMV Capital
EMV Capital Evergreen Fund · 2012 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive
Websitewww.epibone.com

More from EMV Capital Evergreen Fund

Other portfolio companies in the same fund.

Dogtooth Technologies
Active
TMTUK· 2026
AMR Bio
AMR Bio
Active
BiotechUK· 2025
Dname-iT
Active
SoftwareUK· 2023
DeepTech Recycling
DeepTech Recycling
Active
ClimateTechUK· 2022
Ventive
Ventive
Active
TMTUK· 2022
Cetromed
Active
BiotechUK· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track EpiBone

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy EpiBone?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on EpiBone.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue